TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Success of HIFU per-caesarean shots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Montgomery Åsberg Depression Rating Scale (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with radiologically assessed bone healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in self-reported cognition function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of liver transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Achievement of euthyroid state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Composite of major perfusion-related complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fracture Healing Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Healing Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants with Seroresponse at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Fold Rise (GMFR) of Anti-HA Antibodies at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Monitoring adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Perinatal Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: changes in IGD severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in withdrawal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Out-of-control rate of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Dynamic and Static Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Satisfaction Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of uveitic attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Concentration [T(max)] of PBI-200
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritable Bowel Syndrome Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Lille Apathy Rating Scale (LARS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiac mechanoenergetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change on Providers' attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change on Adoption of OTCH among patients
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change on Adoption of OTCH among providers
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of patients with atrial fibrillation mechanisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence rate of hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: incidence rate of infections
Endpoint domain: Adverse events/effects
Primary endpoint: incidence rate of postoperative hematoma or seroma
Endpoint domain: Adverse events/effects
Primary endpoint: Haptotherapeutic Well-Being Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of Colorectal cancer screening completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Abnormal stool blood test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Follow-up colonoscopy after abnormal stool blood test result
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median effective dose (ED50) of ciprofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Research recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Research retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence of CGM use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of unexpected adverse events related to the interventions
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Best Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the integrity of the ocular surface (fluorescein staining)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients revisiting outpatient clinic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Temporomandibular Disorders Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporomandibular Disorders Clinical Examination Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in Hepatic Venous Pressure Gradient (HVPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence and severity of all systemic or ocular treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of pain using the Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of pain using the The State-Trait Anxiety Inventory Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean microvolts of MEPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Humoral immunogenicity of neutralizing antibodies against Delta and Omicron variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Humoral immunogenicity of neutralizing antibodies against Omicron variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of sport-related concussion injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Number of acute traumatic lower body injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Intima-Media Thickness (IMT) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brain oxygen saturation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: The Monreal Cognitive Assessment (MoCA-T)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: The Mini-Mental State Examination Thai (MMSE-T)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tolerability of participants to the treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Evaluate the clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jump flight and contact time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to clinically meaningful progression on motor aspects of daily living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI change Scores in knee Osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of forced expiratory volume in 1 s (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical outcome as assessed by the Oswestry Disability Index (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of multitask deep learning model in judging spinal facet joint degeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F1 score for evaluating severity of facet joints degeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of multitask deep learning model in assessing spinal facet joint degeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Motor Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participant enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participant attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participant retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants reporting solicited administration site events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting serious adverse events (SAEs) within 7 days after each dose
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Monthly Change in self-reported PrEP Adherence from Baseline to 4 month follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly Change in concentration of Tenofovir measured by urine biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants retained in PrEP Care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in suicidality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature difference in limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Independence Measurement (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Following dietary recommendations (mean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Following physical activity recommendations (mean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pregnancy knowledge (mean)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Newborn complications (mean)
Endpoint domain: Adverse events/effects
Primary endpoint: Women weight gain (mean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Six-Minute Walking Test Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Endurance Shuttle Walking Test Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with at least one Adverse Device Event (ADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in Hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of manufacturing anti-FOLR1 chimeric antigen receptor (CAR) T-cells (FH-FOLR1 CAR T) product
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Identify the dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Baseline Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acellular Dermal Matrix graft incorporation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closing of bypass in time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Kujala Patellofemoral Scoring
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of Headache
Endpoint domain: Adverse events/effects
Primary endpoint: AAA screening at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients experiencing a bone event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: vital status at inclusion
Endpoint domain: Mortality/survival
Primary endpoint: date of death
Endpoint domain: Mortality/survival
Primary endpoint: Tidal volumes (Minute Ventilation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Feasibility of morning-only sessions of computerized cognitive training
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility of afternoon/evening-only sessions of computerized cognitive training
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acceptability of morning-only sessions of computerized cognitive training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of afternoon/evening-only sessions of computerized cognitive training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pregnancy-related anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The proportion of subjects who complete all the various measurement steps
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to the MedDiet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall effectiveness of RSV immunoprophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Daily number of steps at 52 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with one or more intubation or anaesthesia related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with failed first-pass intubation
Endpoint domain: Adverse events/effects
Primary endpoint: Microbiota diversity & composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg length Discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of remission of suicidal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants with Improvement in the Appearance of Cellulite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptual forward-masking recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptual gap detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cycles of pemetrexed-cisplatin given
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Deep Neck flexors strength by pressure Biofeedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life SF36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Amount of labiopalatal ridge collapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of bone labial to the implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in central foveal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in appetitive behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in food selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Universal goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inter recti distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-abdominal strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urogynaecological symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NKT-like cells reference values (absolute number and percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Feasibility of MyInspiration:Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of MyInspiration:Data Collection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: General satisfaction of MyInspiration
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total opioids consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of radiotherapy and radioligand therapy related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in total score of Parkinson's Disease Questionnaire-8 (PDQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Disabilities of the Arm Shoulder and Hand short form (QuickDASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Biochemical Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mediterranean Diet Adherence Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Plasma Concentration (Cmax) of ABBV-668
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Cmax (Tmax) of ABBV-668
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRS) scores of 4-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of participants with a screening diagnosis of glaucoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Rate of participants attending follow up exam
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of participants with a screening diagnosis of cataract, diabetic retinopathy, or visual acuity impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Cost comparison of screening program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Correction of coronal deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Occurrence of a severe cardiological event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Agreement between scan modalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: childbirth comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: COVID-19 vaccine uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: COVID-19 vaccine attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative consumption of antiemetics
Endpoint domain: Adverse events/effects
Primary endpoint: CRC Screening Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: The Yesavage Geriatric Depression Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain of the Knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function of the knee
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recommended Phase 2 dose (RP2D) of ociperlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in adolescent Mental Health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to ARI treatment discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of new stroke
Endpoint domain: Mortality/survival
Primary endpoint: Root completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery (10T) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Wound Healing as Assessed by the PUSH Tool 3.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visit Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety and tolerability of SNUG01
Endpoint domain: Adverse events/effects
Primary endpoint: Adult Attention-deficit/hyperactivity disorder Quality-of-Life scale (AAQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) Symptoms Checklist (ASRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as measured by number of participants with Grade 3 and 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of immunochemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mini-Bestest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified-Clinical Test of Sensory Interaction on Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in esophageal distensibility plateau
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: annual incidence rate of status epilepticus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Villus Height to Crypt Depth Ratio (Vh:Cd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Test Score, Pre-Training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test Score, Post-Training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes